Insulin-Like Growth Factor Physiology. What we have Learned from Human Studies.

Endocrinology and Metabolism Clinics of North America

Volumn 41, Issue 2, 2012, Pages 249-263

  Holly, Jeff M P ^a   Perks, Claire M ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Insulin like growth factor binding protein; Insulin like growth factor I; Insulin like growth factor II; Insulin like growth factor receptors

Indexed keywords

CELL SURFACE RECEPTOR; INSULIN; PROTEIN TYROSINE KINASE; SOMATOMEDIN; SOMATOMEDIN B; SOMATOMEDIN B RECEPTOR; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN BINDING PROTEIN 5; SOMATOMEDIN C;

AGING; EXPERIMENTAL MODEL; FRAIL ELDERLY; HUMAN; INFANT NUTRITION; MATERNAL NUTRITION; MUSCLE FUNCTION; MUSCLE MASS; NONHUMAN; PANCREAS ISLET; PANCREAS ISLET BETA CELL; PHYSIOLOGY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; QUALITY OF LIFE; REVIEW; SIGNAL TRANSDUCTION;

AGING; ANIMALS; CELL SURVIVAL; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; MICE; RECEPTORS, SOMATOMEDIN; SEDENTARY LIFESTYLE;

EID: 84861982317     PISSN: 08898529     EISSN: 15584410     Source Type: Journal    
DOI: 10.1016/j.ecl.2012.04.009     Document Type: Review

References (71)

1. Daughaday W.H., Salmon W.D. The origins and development of the somatomedin hypothesis 1999, Humana Press, Totowa (NJ).
2. Froesch E.R., Buergi H., Ramseier E.B., et al. Antibody-suppressible and nonsuppressible insulin-like activities in human serum and their physiologic significance. An insulin assay with adipose tissue of increased precision and specificity. J Clin Invest 1963, 42:1816-1834.
3. Rinderknecht E., Humbel R.E. Amino-terminal sequences of two polypeptides from human serum with nonsuppressible insulin-like and cell-growth-promoting activities: evidence for structural homology with insulin B chain. Proc Natl Acad Sci U S A 1976, 73(12):4379-4381.
4. Kim J.J., Accili D. Signalling through IGF-I and insulin receptors: where is the specificity?. Growth Horm IGF Res 2002, 12(2):84-90.
5. Ghosh P., Dahms N.M., Kornfeld S. Mannose 6-phosphate receptors: new twists in the tale. Nature reviews. Mol Cell Biol 2003, 4(3):202-212.
6. Xu S., Cwyfan-Hughes S.C., van der Stappen J.W., et al. Insulin-like growth factors (IGFs) and IGF-binding proteins in human skin interstitial fluid. J Clin Endocrinol Metab 1995, 80(10):2940-2945.
7. Holly J., Perks C. The role of insulin-like growth factor binding proteins. Neuroendocrinology 2006, 83(3-4):154-160.
8. Bar R.S., Clemmons D.R., Boes M., et al. Transcapillary permeability and subendothelial distribution of endothelial and amniotic fluid insulin-like growth factor binding proteins in the rat heart. Endocrinology 1990, 127(3):1078-1086.
9. Holly J.M. The physiological role of IGFBP-1. Acta Endocrinol 1991, 124(Suppl 2):55-62.
10. Payet L.D., Firth S.M., Baxter R.C. The role of the acid-labile subunit in regulating insulin-like growth factor transport across human umbilical vein endothelial cell monolayers. J Clin Endocrinol Metab 2004, 89(5):2382-2389.
11. Maile L.A., Holly J.M. Insulin-like growth factor binding protein (IGFBP) proteolysis: occurrence, identification, role and regulation. Growth Horm IGF Res 1999, 9(2):85-95.
12. Maile L.A., Xu S., Cwyfan-Hughes S.C., et al. Active and inhibitory components of the insulin-like growth factor binding protein-3 protease system in adult serum, interstitial, and synovial fluid. Endocrinology 1998, 139(12):4772-4781.
13. Xu S., Savage P., Burton J.L., et al. Proteolysis of insulin-like growth factor-binding protein-3 by human skin keratinocytes in culture in comparison to that in skin interstitial fluid: the role and regulation of components of the plasmin system. J Clin Endocrinol Metab 1997, 82(6):1863-1868.
14. Whellams E.J., Maile L.A., Fernihough J.K., et al. Alterations in insulin-like growth factor binding protein-3 proteolysis and complex formation in the arthritic joint. J Endocrinol 2000, 165(3):545-556.
15. Chen B.K., Overgaard M.T., Bale L.K., et al. Molecular regulation of the IGF-binding protein-4 protease system in human fibroblasts: identification of a novel inducible inhibitor. Endocrinology 2002, 143(4):1199-1205.
16. Martin B., Ji S., Maudsley S., et al. " Control" laboratory rodents are metabolically morbid: why it matters. Proc Natl Acad Sci U S A 2010, 107(14):6127-6133.
17. Renehan A.G., Bhaskar P., Painter J.E., et al. The prevalence and characteristics of colorectal neoplasia in acromegaly. J Clin Endocrinol Metab 2000, 85(9):3417-3424.
18. Sheldon C.A., Williams R.D., Fraley E.E. Incidental carcinoma of the prostate: a review of the literature and critical reappraisal of classification. J Urol 1980, 124(5):626-631.
19. Gluckman P.D., Pinal C.S. Regulation of fetal growth by the somatotrophic axis. J Nutr 2003, 133(5 Suppl 2):1741S-1746S.
20. Reik W., Constancia M., Fowden A., et al. Regulation of supply and demand for maternal nutrients in mammals by imprinted genes. J Physiol 2003, 547(Pt 1):35-44.
21. Vu T.H., Jirtle R.L., Hoffman A.R. Cross-species clues of an epigenetic imprinting regulatory code for the IGF2R gene. Cytogenet Genome Res 2006, 113(1-4):202-208.
22. Holly J.M. The IGF-II enigma. Growth Horm IGF Res 1998, 8(3):183-184.
23. O'Dell S.D., Miller G.J., Cooper J.A., et al. ApaI polymorphism in insulin-like growth factor II (IGF2) gene and weight in middle-aged males. Int J Obes Relat Metab Disord 1997, 21(9):822-825.
24. Rodriguez S., Gaunt T.R., O'Dell S.D., et al. Haplotypic analyses of the IGF2-INS-TH gene cluster in relation to cardiovascular risk traits. Hum Mol Genet 2004, 13(7):715-725.
25. Rice T., Chagnon Y.C., Perusse L., et al. A genomewide linkage scan for abdominal subcutaneous and visceral fat in black and white families: the HERITAGE Family Study. Diabetes 2002, 51(3):848-855.
26. Sandhu M.S., Gibson J.M., Heald A.H., et al. Low circulating IGF-II concentrations predict weight gain and obesity in humans. Diabetes 2003, 52(6):1403-1408.
27. Heald A.H., Karvestedt L., Anderson S.G., et al. Low insulin-like growth factor-II levels predict weight gain in normal weight subjects with type 2 diabetes. Am J Med 2006, 119(2):167.e9-167.e15.
28. Martin R.M., Holly J.M., Davey Smith G., et al. Associations of adiposity from childhood into adulthood with insulin resistance and the insulin-like growth factor system: 65-year follow-up of the Boyd Orr Cohort. J Clin Endocrinol Metab 2006, 91(9):3287-3295.
29. Jeyaratnaganthan N., Hojlund K., Kroustrup J.P., et al. Circulating levels of insulin-like growth factor-II/mannose-6-phosphate receptor in obesity and type 2 diabetes. Growth Horm IGF Res 2010, 20(3):185-191.
30. Heald A.H., Kaushal K., Siddals K.W., et al. Insulin-like growth factor binding protein-2 (IGFBP-2) is a marker for the metabolic syndrome. Exp Clin Endocrinol Diabetes 2006, 114(7):371-376.
31. Zhao Y., Ma Y.S., Fang Y., et al. IGF2BP2 genetic variation and type 2 diabetes: a global meta-analysis. DNA Cell Biol 2011, [Epub ahead of print].
32. Jia H., Yu L., Jiang Z., et al. Association between IGF2BP2 rs4402960 polymorphism and risk of type 2 diabetes mellitus: a meta-analysis. Arch Med Res 2011, 42(5):361-367.
33. Rodriguez S., Eiriksdottir G., Gaunt T.R., et al. IGF2BP1, IGF2BP2 and IGF2BP3 genotype, haplotype and genetic model studies in metabolic syndrome traits and diabetes. Growth Horm IGF Res 2010, 20(4):310-318.
34. Murphy R., Baptista J., Holly J., et al. Severe intrauterine growth retardation and atypical diabetes associated with a translocation breakpoint disrupting regulation of the insulin-like growth factor 2 gene. J Clin Endocrinol Metab 2008, 93(11):4373-4380.
35. Denley A., Bonython E.R., Booker G.W., et al. Structural determinants for high-affinity binding of insulin-like growth factor II to insulin receptor (IR)-A, the exon 11 minus isoform of the IR. Mol Endocrinol 2004, 18(10):2502-2512.
36. Pandini G., Conte E., Medico E., et al. IGF-II binding to insulin receptor isoform A induces a partially different gene expression profile from insulin binding. Ann N Y Acad Sci 2004, 1028:450-456.
37. Sacco A., Morcavallo A., Pandini G., et al. Differential signaling activation by insulin and insulin-like growth factors I and II upon binding to insulin receptor isoform A. Endocrinology 2009, 150(8):3594-3602.
38. Morcavallo A., Genua M., Palummo A., et al. Insulin and insulin-like growth factor II differentially regulate endocytic sorting and stability of the insulin receptor isoform A. J Biol Chem 2012, 287(14):11422-11436.
39. Barker D.J., Winter P.D., Osmond C., et al. Weight in infancy and death from ischaemic heart disease. Lancet 1989, 2(8663):577-580.
40. Kajantie E. Early-life events. Effects on aging. Hormones (Athens) 2008, 7(2):101-113.
41. Barker D.J. The developmental origins of adult disease. J Am Coll Nutr 2004, 23(Suppl 6):588S-595S.
42. Barker D.J., Gluckman P.D., Godfrey K.M., et al. Fetal nutrition and cardiovascular disease in adult life. Lancet 1993, 341(8850):938-941.
43. Symonds M.E., Gardner D.S. Experimental evidence for early nutritional programming of later health in animals. Curr Opin Clin Nutr Metab Care 2006, 9(3):278-283.
44. Langley-Evans S.C. Nutritional programming of disease: unravelling the mechanism. J Anat 2009, 215(1):36-51.
45. Rogers I., Metcalfe C., Gunnell D., et al. Insulin-like growth factor-I and growth in height, leg length, and trunk length between ages 5 and 10 years. J Clin Endocrinol Metab 2006, 91(7):2514-2519.
46. Rogers I.S., Gunnell D., Emmett P.M., et al. Cross-sectional associations of diet and insulin-like growth factor levels in 7- to 8-year-old children. Cancer Epidemiol Biomarkers Prev 2005, 14(1):204-212.
47. Thissen J.P., Ketelslegers J.M., Underwood L.E. Nutritional regulation of the insulin-like growth factors. Endocr Rev 1994, 15(1):80-101.
48. Rogers I., Emmett P., Gunnell D., et al. Milk as a food for growth? The insulin-like growth factors link. Public Health Nutr 2006, 9(3):359-368.
49. Hoppe C., Udam T.R., Lauritzen L., et al. Animal protein intake, serum insulin-like growth factor I, and growth in healthy 2.5-y-old Danish children. Am J Clin Nutr 2004, 80(2):447-452.
50. Hoppe C., Molgaard C., Juul A., et al. High intakes of skimmed milk, but not meat, increase serum IGF-I and IGFBP-3 in eight-year-old boys. Eur J Clin Nutr 2004, 58(9):1211-1216.
51. Zhu K., Du X., Cowell C.T., et al. Effects of school milk intervention on cortical bone accretion and indicators relevant to bone metabolism in Chinese girls aged 10-12 y in Beijing. Am J Clin Nutr 2005, 81(5):1168-1175.
52. Larnkjaer A., Hoppe C., Molgaard C., et al. The effects of whole milk and infant formula on growth and IGF-I in late infancy. Eur J Clin Nutr 2009, 63(8):956-963.
53. Rich-Edwards J.W., Ganmaa D., Pollak M.N., et al. Milk consumption and the prepubertal somatotropic axis. Nutr J 2007, 6:28.
54. Ostman E.M., Liljeberg Elmstahl H.G., Bjorck I.M. Inconsistency between glycemic and insulinemic responses to regular and fermented milk products. Am J Clin Nutr 2001, 74(1):96-100.
55. Brismar K., Fernqvist-Forbes E., Wahren J., et al. Effect of insulin on the hepatic production of insulin-like growth factor-binding protein-1 (IGFBP-1), IGFBP-3, and IGF-I in insulin-dependent diabetes. J Clin Endocrinol Metab 1994, 79(3):872-878.
56. Chellakooty M., Juul A., Boisen K.A., et al. A prospective study of serum insulin-like growth factor I (IGF-I) and IGF-binding protein-3 in 942 healthy infants: associations with birth weight, gender, growth velocity, and breastfeeding. J Clin Endocrinol Metab 2006, 91(3):820-826.
57. Savino F., Fissore M.F., Grassino E.C., et al. Ghrelin, leptin and IGF-I levels in breast-fed and formula-fed infants in the first years of life. Acta Paediatr 2005, 94(5):531-537.
58. Martin R.M., Holly J.M., Smith G.D., et al. Could associations between breastfeeding and insulin-like growth factors underlie associations of breastfeeding with adult chronic disease? The Avon Longitudinal Study of Parents and Children. Clin Endocrinol 2005, 62(6):728-737.
59. Larnkjaer A., Ingstrup H.K., Schack-Nielsen L., et al. Early programming of the IGF-I axis: negative association between IGF-I in infancy and late adolescence in a 17-year longitudinal follow-up study of healthy subjects. Growth Horm IGF Res 2009, 19(1):82-86.
60. Ben-Shlomo Y., Holly J., McCarthy A., et al. Prenatal and postnatal milk supplementation and adult insulin-like growth factor I: long-term follow-up of a randomized controlled trial. Cancer Epidemiol Biomarkers Prev 2005, 14(5):1336-1339.
61. Martin R.M., Holly J.M., Middleton N., et al. Childhood diet and insulin-like growth factors in adulthood: 65-year follow-up of the Boyd Orr Cohort. Eur J Clin Nutr 2007, 61(11):1281-1292.
62. Elias S.G., Keinan-Boker L., Peeters P.H., et al. Long term consequences of the 1944-1945 Dutch famine on the insulin-like growth factor axis. Int J Cancer 2004, 108(4):628-630.
63. Soliman A.T., Hassan A.E., Aref M.K., et al. Serum insulin-like growth factors I and II concentrations and growth hormone and insulin responses to arginine infusion in children with protein-energy malnutrition before and after nutritional rehabilitation. Pediatr Res 1986, 20(11):1122-1130.
64. Holly J.M., Amiel S.A., Sandhu R.R., et al. The role of growth hormone in diabetes mellitus. J Endocrinol 1988, 118(3):353-364.
65. Barzilai N., Bartke A. Biological approaches to mechanistically understand the healthy life span extension achieved by calorie restriction and modulation of hormones. J Gerontol A Biol Sci Med Sci 2009, 64(2):187-191.
66. Kenyon C.J. The genetics of ageing. Nature 2010, 464(7288):504-512.
67. Fontana L., Partridge L., Longo V.D. Extending healthy life span-from yeast to humans. Science 2010, 328(5976):321-326.
68. Ziv E., Hu D. Genetic variation in insulin/IGF-1 signaling pathways and longevity. Ageing Res Rev 2011, 10(2):201-204.
69. Ceda G.P., Dall'Aglio E., Morganti S., et al. Update on new therapeutic options for the somatopause. Acta Biomed 2010, 81(Suppl 1):67-72.
70. Perrini S., Laviola L., Carreira M.C., et al. The GH/IGF1 axis and signaling pathways in the muscle and bone: mechanisms underlying age-related skeletal muscle wasting and osteoporosis. J Endocrinol 2010, 205(3):201-210.
71. Thorner M.O. Statement by the Growth Hormone Research Society on the GH/IGF-I axis in extending health span. J Gerontol A Biol Sci Med Sci 2009, 64(10):1039-1044.